GFAP and Alzheimer disease: Plasma biomarkers for Aβ42/40, p-tau 181, neurofilament light chain (NfL), and GFAP are suggested to be informative in addition to CSF [5], and specific MRI radiomics features may offer thorough and sensitive information about various brain regions, revealing AD pathological mechanisms and facilitating early diagnosis [9].